Skip to content

A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511770-76-00
Acronym
IBC-01-01
Enrollment
1
Registered
2024-06-28
Start date
2023-10-31
Completion date
2025-10-21
Last updated
2025-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

None listed

Sponsors

Immunobrain Checkpoint Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026